Allan D. Kirk, MD, PhD, Chair of the Duke Department of Surgery, has been elected to the National Academy of Medicine, one of the highest honors bestowed upon healthcare professionals and scientists.
Dr. Kirk was among 79 other individuals elected to the academy yesterday, including Donald P. McDonnell, PhD, and Robert M. Califf, MD, also from Duke. Membership in the academy recognizes individuals who have made significant contributions to the advancement of the medical sciences, health care, and public health.
From National Academy of Medicine President Victor J. Dzau, MD:
“These newly elected members are outstanding professionals who care deeply about advancing health and health care in the U.S. and globally. Their expertise will help our organization address pressing health challenges and improve health, science, and medicine for the benefit of us all. It is my privilege to welcome these accomplished individuals to the National Academy of Medicine.”
Dr. Kirk serves as Chairman of the Department of Surgery and Surgeon-in-Chief for the Duke University Health System. He is an internationally recognized expert in transplant immunology. His research focuses on the translational development of anti-rejection therapies in organ transplantation.
Dr. Kirk maintains a clinical kidney transplant practice and a laboratory effort with active funding from the National Institutes of Health (NIH), the Food and Drug Administration, and the Department of Defense. He is the Editor-in-Chief of the American Journal of Transplantation and has published more than 250 manuscripts in the peer-reviewed literature.
Dr. Kirk received his medical degree from the Duke University School of Medicine and a PhD in immunology at Duke. He completed a general surgery residency at Duke, followed by an organ transplant fellowship at the University of Wisconsin.
From 1997 to 2001, he served in the United States Navy, reaching the rank of commander and principal investigator at the Naval Medical Research Center. He served as a Senior Investigator at the NIH and as Chief of the Transplantation Branch for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) from 2001-2007. In 2007, he joined Emory University as Professor and Vice Chair for Surgical Research. Since 2014, he has been in his current position at Duke.